STONEPINE CAPITAL MANAGEMENT, LLC Aerie Pharmaceuticals, Inc. Transaction History

STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:

$0
portfolio value

STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+101.73%
quarter

Aerie Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -251.23K shares -1.88M $15.13 0
Q2 2022 share Increase +167.56% 157.33K shares 1.03M $7.5 251.23K
Q1 2022 share Increase 0.00% 93.9K shares 854K $9.1 93.9K